Konu "ibrutinib" için WoS İndeksli Yayınlar Koleksiyonu listeleme
Toplam kayıt 1, listelenen: 1-1
-
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL
(Elsevier Inc., 2022)Introduction/Background: The emergence of novel agents targeting the B-cell receptor pathway and BCL-2 has significantly changed the therapeutic landscape of CLL. We evaluated the safety and efficacy of single-agent ibrutinib ...